Clients with Renal Impairment Ritalin LA has not been examined in renally-impaired people. Renal impairment is predicted to possess minimum effect on the pharmacokinetics of methylphenidate given that less than 1% of a radiolabeled dose is excreted from the urine as unchanged compound, and the foremost metabolite (ritalinic acid), has little if any

Article Under Review